A Comprehensive Review of the Potential Use of Green Tea Polyphenols in the Management of COVID-19

Evidence-based Complementary and Alternative Medicine - Tập 2021 - Trang 1-13 - 2021
Trina Ekawati Tallei1, Fatimawali Fatimawali2, Nurdjannah J. Niode3, Rinaldi Idroes4, B. M. Redwan Matin Zidan5, Saikat Mitra5, İsmail Çeli̇k6, Firzan Nainu7, Duygu Ağagündüz8, Talha Bin Emran9, Raffaele Capasso10
1Department of Biology, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado, North Sulawesi 95115, Indonesia
2Pharmacy Study Program, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado, North Sulawesi 95115, Indonesia
3Department of Dermatology and Venereology, Faculty of Medicine, Sam Ratulangi University, Manado, North Sulawesi 95115, Indonesia
4Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Kopelma Darussalam, Banda Aceh 23111, Indonesia
5Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
6Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University, Kayseri 38039, Turkey
7Faculty of Pharmacy, Hasanuddin University, Makassar, South Sulawesi 90245, Indonesia
8Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Emek, Ankara 06490, Turkey
9Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, 4381, Bangladesh
10Department of Agricultural Sciences, University of Naples “Federico II”, 80055 Portici (Naples), Italy

Tóm tắt

Green tea is produced from Camellia sinensis (L.) buds and leaves that have not gone through the oxidation and withering processes used to produce black and oolong teas. It was originated in China, but its cultivation and production have expanded to other Eastern Asian countries. Several polyphenolic compounds, including flavandiols, flavonols, flavonoids, and phenolic acids, are found in green tea and may constitute greater than 30% of the dry weight. Flavonols, especially catechins, represent the majority of green tea polyphenols. Green tea polyphenolic compounds have been reported to confer several health benefits. This review describes the potential use of green tea polyphenols in the management of coronavirus disease 2019 (COVID-19). The immunomodulatory, antibacterial, antioxidant, and anti-inflammatory effects of green tea polyphenols have also been considered in this review. In addition to describing the bioactivities associated with green tea polyphenols, this review discusses the potential delivery of these biomolecules using a nanoparticle drug delivery system. Moreover, the bioavailability and toxicity of green tea polyphenols are also evaluated.

Từ khóa


Tài liệu tham khảo

10.1186/s12906-015-0643-2

10.1177/1934578x1501001025

10.1016/j.dib.2019.104681

10.1016/j.bbrep.2019.100715

10.1155/2020/6307457

10.3390/molecules25173936

10.3390/ijms20246196

10.1016/j.lwt.2015.01.003

10.1080/10408398.2017.1347556

10.1016/j.jamcollsurg.2006.01.018

10.1186/1749-8546-5-13

10.1002/biof.5520130121

10.1039/b102541b

10.1080/07315724.2007.10719634

10.1186/1472-6882-11-15

10.3945/ajcn.113.059584

10.1016/s0040-4039(00)99983-0

10.1021/jf804025c

10.1021/jf0730338

10.3945/ajcn.112.052746

10.1155/2018/9105261

10.1016/0166-3542(93)90008-7

10.1248/bpb.29.2226

10.2741/1421

10.3390/molecules23102475

10.1111/jaac.12436

10.2171/jao.46.110

10.11402/cookeryscience.50.182

10.3390/foods9040483

10.1021/jf0525232

10.1177/1934578X1601100835

10.3389/fpls.2019.00939

10.1126/science.abc1560

10.1016/j.antiviral.2005.06.010

10.1371/currents.rrn1052

10.1021/jf901128u

10.1080/07391102.2020.1758791

10.1080/07391102.2020.1758790

10.1080/07391102.2020.1761881

10.1080/07391102.2020.1760136

10.1080/07391102.2020.1767691

10.1016/j.antiviral.2018.07.012

10.1080/07391102.2020.1753577

10.3390/molecules26123572

10.1080/07391102.2020.1802347

10.3389/fimmu.2019.00336

10.1016/j.cmi.2020.07.016

10.1186/s12879-020-05374-z

10.1016/j.chom.2016.01.001

10.1186/s13613-020-00736-x

10.1111/j.1574-6968.1997.tb10424.x

10.1616/1476-2137.14184

10.1016/s0891-5849(02)01366-7

10.1093/jac/dkp094

10.1080/09168451.2014.993356

10.1128/AAC.49.7.2914-2920.2005

10.1128/MMBR.67.4.686-723.2003

10.3390/molecules26051200

10.1038/s41591-020-0965-6

10.1155/2013/865638

10.18773/austprescr.2017.037

10.2174/1871523015666160915154443

10.1038/sj.onc.1209829

10.1007/s13105-014-0345-0

10.1177/154405910708600412

10.3892/or.2017.5362

10.1016/j.febslet.2011.02.010

10.1016/j.bbrc.2012.08.096

10.1177/2058739219857576

10.1248/bpb.29.1120

10.1016/j.envpol.2019.06.029

10.1046/j.1365-4362.1999.00796.x

10.1590/S0102-865020150040000002

10.1017/S000711451000560X

10.1093/jn/131.7.2034

10.1016/j.niox.2020.06.002

10.3390/medicina56080386

10.1016/j.mehy.2020.110102

10.1002/mnfr.201000641

10.1093/jn/131.1.27

10.1016/j.foodchem.2017.08.117

10.11604/pamj.2020.35.2.22877

10.1093/jn/127.5.962S

10.1111/jfbc.13557

10.3389/fimmu.2020.590716

10.1136/jim-2016-000158

10.14202/vetworld.2018.765-770

10.4103/0973-8258.126824

10.3109/08923973.2014.953637

10.1186/s12950-015-0097-9

10.1177/15347354211002647

10.2147/JIR.S271292

10.1016/j.mehy.2020.109844

10.1056/NEJMoa2001191

10.1128/mBio.00398-20

10.3389/fphar.2017.00618

10.3389/fimmu.2017.00550

10.1067/mai.2000.110556

10.7150/ijbs.46891

10.3390/ijms21145171

10.1080/21655979.2019.1632669

10.1016/j.foodres.2009.08.016

10.1111/1750-3841.12112

10.1016/j.jnutbio.2013.10.002

10.1023/a:1016085108889

10.1039/c2cc17295j

10.1080/01635581.2010.509537

10.1002/9781118864463.ch19

10.1016/j.tifs.2014.08.006

10.1007/s11947-012-0944-0

10.1023/a:1011975120776

10.1023/a:1016009313548

10.1016/j.ddtec.2005.05.019

10.1124/dmd.112.044925

10.3390/nu8050307

10.1016/j.foodhyd.2014.05.010

10.1093/ajcn/80.6.1558

10.1207/S15327914NC4502_13

10.1124/dmd.30.11.1246

10.1016/j.foodres.2012.08.004

10.1016/j.ijpharm.2004.08.020

10.1016/j.jnutbio.2016.01.002

10.1021/jf304116s

H. H. Chow, 2003, Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 9, 3312

H. H. Chow, 2001, Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, Cancer Epidemiology, Biomarkers & Prevention, 10, 53

10.1016/j.bmc.2004.08.002

10.1016/s0167-4889(01)00175-6

10.3109/08982104.2013.788023

10.1097/CAD.0b013e32832d6834

10.1211/0022357044003

10.1049/iet-nbt.2016.0147

10.1016/j.foodhyd.2017.01.041

10.1158/1535-7163.MCT-07-0058

Y. Shukla, 2007, Tea and cancer chemoprevention: a comprehensive review, Asian Pacific Journal of Cancer Prevention, 8, 155

10.1593/neo.05652

10.1016/j.taap.2006.11.024

10.1016/j.tox.2009.03.007

10.1021/mp700071d

10.4049/jimmunol.2000413

10.1158/1078-0432.CCR-04-2549

Thông tin
Thông tin xuất bản

Evidence-based Complementary and Alternative Medicine

Tập 2021

1-13

Thông tin tác giả